Though anti-VEGF therapies are generally well tolerated and in use since decades, hypertension, renal insufficiency, Fatigue/asthenia, nausea-vomiting are common side effect seen with TK/VEGF-directed treatment [45]. This evidence concerns the gene VEGFA and hypertensive disorder.